SNCA and Parkinson disease: Similarly, using a dead Cas9-Suntag system for precise locus-specific modifications, reducing H3K4me3 levels at the SNCA promoter resulted in lower α-synuclein expression in neuronal cell lines and PD-derived induced pluripotent stem cells (iPSCs) [192].